EVAX FY 2025 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena

EVAXEvaxion Biotech A/S

$20M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+125.8% YoY

Gross Profit

$00.0% margin

Operating Income

-$9M-122.7% margin

Net Income

-$8M-102.4% margin

EPS (Diluted)

$-1.21

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$28M

Total Liabilities

$11M

Stockholders' Equity

$17M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$3M	+125.8%
Gross Profit	$0	$3M	-100.0%
Operating Income	-$9M	-$15M	+37.1%
Net Income	-$8M	-$11M	+26.8%